Solascure

Developer of biologic therapies for the treatment of chronic wounds

placeCambridge, England, United Kingdom calendar_todayFounded 2017 groups11 employees language solascure.com

Registered entities

Social engagement

Social engagement: 1.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

68 investors on record; lead investors include Seneca.

Investor typeCountShare
Venture capital34%
Private equity34%
Angel & family office11%
Accelerator & incubator11%
Other / undisclosed6088%

Recent activity

28 May 2026
Milestone
regulatory
5 May 2026
Event
EWMA-DEWU 2026
27 Apr 2026
Recognition
Coming soon